The solution, according to the present invention, concerns the lipid nanostructural form of the heparin sodium salt for dermal applications, of a viscosity not less than 7000 cP, characterized by the fact that it consists of: heparin, or a pharmaceutically acceptable salt thereof, liposomes and/or hydrogel, proteolytic enzymes of plant origin or their stabilized derivative, preferably chitosan, positive polyions, organic solvents, buffer and gelling agents and optionally: preservatives, antioxidants, and a method for the preparation of a lipid nanostructural form of heparin sodium salt for dermal applications.
